CIK 0001645469
- Non-accelerated filer
- Smaller reporting company
Monopar Therapeutics
Sign in to watch- Ticker
- MNPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320463781
- Phone
- +1 847-388-0349
- Business address
- 1000 SKOKIE BLVD SUITE 350, WILMETTE, IL, 60091
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,335,315
- in 9 filings, $5.3M under 10b5-1 plans
Net −$5,335,315. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-02 | KLAUSNER ARTHUR J Director | Grant or award · Restricted Stock Units | +11,436 | 11,436 | ||
| 2022-02-02 | Cittadine Andrew Chief Operating Officer | Grant or award · Stock Options | +85,000 | 85,000 | ||
| 2022-02-02 | Cittadine Andrew Chief Operating Officer | Grant or award · Restricted Stock Units | +65,000 | 65,000 | ||
| 2022-01-01 | Mazar Andrew Paul Chief Scientific Officer | Exercise or conversion | +1,937 | 21,660.8 | ||
| 2022-01-01 | Mazar Andrew Paul Chief Scientific Officer | Shares withheld for taxes | −671 | $3.21 | $2K | 20,989.8 |
| 2022-01-01 | Mazar Andrew Paul Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −1,937 | 3,874 | ||
| 2022-01-01 | Tsuchimoto Kim R Chief Financial Officer | Exercise or conversion | +1,231 | 5,420 | ||
| 2022-01-01 | Tsuchimoto Kim R Chief Financial Officer | Shares withheld for taxes | −505 | $3.21 | $2K | 4,915 |
| 2022-01-01 | Tsuchimoto Kim R Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −1,231 | 2,461 | ||
| 2022-01-01 | Robinson Chandler Chief Executive Officer | Exercise or conversion | +6,724 | 36,059.8 | ||
| 2022-01-01 | Robinson Chandler Chief Executive Officer | Shares withheld for taxes | −2,327 | $3.21 | $7K | 33,732.8 |
| 2022-01-01 | Robinson Chandler Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −6,724 | 13,447 | ||
| 2022-01-01 | RIOUX PATRICE Acting Chief Medical Officer | Grant or award · Stock Options | +10,000 | 10,000 | ||
| 2021-12-31 | Mazar Andrew Paul Chief Scientific Officer | Exercise or conversion | +1,606 | 20,279.8 | ||
| 2021-12-31 | Mazar Andrew Paul Chief Scientific Officer | Shares withheld for taxes | −556 | $3.21 | $2K | 19,723.8 |
| 2021-12-31 | Mazar Andrew Paul Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −1,606 | 19,273 | ||
| 2021-12-31 | Tsuchimoto Kim R Chief Financial Officer | Exercise or conversion | +1,221 | 4,690 | ||
| 2021-12-31 | Tsuchimoto Kim R Chief Financial Officer | Shares withheld for taxes | −501 | $3.21 | $2K | 4,189 |
| 2021-12-31 | Tsuchimoto Kim R Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −1,221 | 14,652 | ||
| 2021-12-31 | Robinson Chandler Chief Executive Officer | Exercise or conversion | +3,941 | 30,699.8 |
Page 20 of 28 · 549 trades